World Thalassaemia Day is marked each year on 8 May to draw attention to thalassaemia, a group of inherited blood disorders in which the body cannot make haemoglobin properly. The day is coordinated internationally by the Thalassaemia International Federation and its partners, and is used by patient groups, clinicians and health authorities as a fixed annual opportunity to highlight prevention, timely diagnosis and access to safe treatment.
Why it matters
Thalassaemia becomes a serious disease when a child inherits the altered gene from both parents, even if the parents themselves have no symptoms. Children with severe forms, such as thalassaemia major, often develop profound anaemia in early life and may depend on regular blood transfusions for survival, along with medicines to remove excess iron that builds up from transfusions. In countries where the carrier rate is significant, many couples only discover that they are both carriers after the birth of an affected child, creating emotional, medical and financial stress for the whole family. World Thalassaemia Day underscores how informed choices, such as premarital or pre-pregnancy carrier screening and genetic counselling, can help prevent new severe cases while also strengthening support for those already living with the condition.
History
World Thalassaemia Day has been observed since 1994 under the leadership of the Thalassaemia International Federation, which represents patients, families and clinicians from many countries. The day was established to remember those who have lost their lives to thalassaemia and to honour the dedication of patients who live with the disorder and the families, donors and health professionals who support them. Over time, it has evolved into a broad platform for awareness campaigns about inheritance patterns, early diagnosis in childhood and improved access to comprehensive care, including safe blood transfusion services and appropriate monitoring for iron overload.
Key facts
Common conditions
- beta thalassaemia major
- beta thalassaemia intermedia
- thalassaemia trait or carrier state
- chronic haemolytic anaemia
- iron overload due to transfusions
- complications related to long-term transfusion therapy
Who is most affected
- children born to two carrier parents
- families with a known history of thalassaemia
- communities with a higher carrier rate
- people who depend on regular blood transfusions
- caregivers who manage lifelong treatment
What you can do
- learn about thalassaemia inheritance before marriage
- consider premarital carrier screening
- discuss family history of anaemia with your doctor
- seek genetic counselling if both partners are carriers
- support safe blood donation and thalassaemia foundations
In Bangladesh
Bangladesh has one of the higher estimated carrier rates for thalassaemia in the region, with a significant proportion of the population carrying the gene without symptoms. In response, national experts, universities and patient organisations have increased advocacy for premarital and pre-pregnancy carrier screening so that couples can understand their risk before having children. Specialised centres, including facilities at institutions such as BSMMU and organisations like Thalassaemia Foundation Bangladesh, provide diagnostic services, regular transfusion support and counselling for affected families. World Thalassaemia Day offers a focal point each year to promote these services, encourage voluntary blood donation and build public understanding that thalassaemia is largely preventable when carrier status is known in advance.
Frequently asked questions
- How is thalassaemia inherited?
- A child develops thalassaemia major only if both parents carry the gene mutation, even if the parents show no symptoms themselves.
- Why is premarital screening recommended in Bangladesh?
- Because Bangladesh has a relatively high thalassaemia carrier rate, screening before marriage helps couples understand their risk of having an affected child.